PrEP awareness and use among reproductive age women in Miami, Florida.

<h4>Background</h4>Miami, Florida is an epicenter of the HIV epidemic in the US, with 20% of new HIV infections occurring in women. Despite effectiveness of Pre-Exposure Prophylaxis (PrEP) in preventing HIV, only 10% of eligible women benefit from its use.<h4>Setting</h4>This...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Nicholas Fonseca Nogueira, Nicole Luisi, Ana S Salazar, Emily M Cherenack, Patricia Raccamarich, Nichole R Klatt, Deborah L Jones, Maria L Alcaide
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Online Access:	https://doi.org/10.1371/journal.pone.0286071

Similar Items

Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.
by: Young Jo, et al.
Published: (2020-01-01)

Predictors of PrEP awareness, PrEP discussion and interest in long‐acting injectable PrEP among Filipina transfeminine adults
by: Arjee Javellana Restar, et al.
Published: (2023-06-01)

An observational cohort study evaluating PrEP reach, engagement and persistence through a community‐based mobile clinic in Miami‐Dade County, Florida
by: Susanne Doblecki‐Lewis, et al.
Published: (2024-10-01)

Addressing disparities in Pre-exposure Prophylaxis (PrEP) access: implementing a community-centered mobile PrEP program in South Florida
by: Stefani A. Butts, et al.
Published: (2023-11-01)

Minority adolescents’ HIV PrEP awareness and preferences in Alabama
by: Henna Budhwani, et al.
Published: (2025-05-01)

Pre-Exposure Prophylaxis (PrEP) Awareness Is Low Among Heterosexual People of Color Who Might Benefit From PrEP in Philadelphia
by: Alexis M. Roth, et al.
Published: (2019-05-01)

Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
by: Connie Celum, et al.
Published: (2023-07-01)

Centering PrEP: Utilizing ADAPT-ITT to inform group PrEP care for sex workers in Chicago
by: Randi Beth Singer, et al.
Published: (2024-01-01)

PrEP Acceptance among Eligible Patients Attending the Largest PrEP Clinic in Jackson, Mississippi
by: Madison R. Hollcroft MPH, et al.
Published: (2023-04-01)

Understanding the Association between PrEP Stigma and PrEP Cascade Moderated by the Intensity of HIV Testing
by: Chen Zhang, et al.
Published: (2022-05-01)

Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women
by: Alina Cernasev, et al.
Published: (2021-06-01)

Scales to Assess Knowledge, Motivation, and Self-Efficacy for HIV PrEP in Colombian MSM: PrEP-COL Study
by: Héctor F. Mueses-Marín, et al.
Published: (2021-01-01)

Cost effectiveness of PrEP in Europe
by: Brooke Nichols
Published: (2018-05-01)

Pathopolitics: Pathologies and Biopolitics of PrEP
by: Tankut Atuk
Published: (2020-08-01)

Understanding PrEP misconceptions and their impact on PrEP initiation and use among pregnant and lactating women in Malawi.
by: Alinda M Nyamaizi, et al.
Published: (2025-01-01)

HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study
by: Christina Psaros, et al.
Published: (2024-05-01)

Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement
by: Patrick Ahaus, et al.
Published: (2022-09-01)

Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda.
by: Timothy R Muwonge, et al.
Published: (2020-01-01)

Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort
by: Diana Canetti, et al.
Published: (2022-12-01)

Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada.
by: Maxime Charest, et al.
Published: (2021-01-01)

Relationship between the practice of chemsex and taking PrEP
by: O. De Juan Viladegut, et al.
Published: (2024-04-01)

Oral PrEP for HIV prevention. It works
by: Erica Pool, et al.
Published: (2015-07-01)

PrEP use and willingness cascades among GBMSM in 15 Asian countries/territories: an analysis of the PrEP APPEAL survey
by: Gede Benny Setia Wirawan, et al.
Published: (2025-04-01)

PrEP initiation and adherence among Black cisgender women in Mississippi: The role of HIV and PrEP stigma and social support
by: Deja Knight, et al.
Published: (2024-11-01)

Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland
by: Rose Pollard Kaptchuk, et al.
Published: (2024-05-01)

“When he is around, I’ll take the PrEP, but when he is not, I will not take PrEP”: key influences on PrEP use decisions among women attending family planning clinics in Kenya
by: Vallery Ogello, et al.
Published: (2025-07-01)

PrEP discontinuation, cycling, and risk: Understanding the dynamic nature of PrEP use among female sex workers in South Africa.
by: Lillian M Shipp, et al.
Published: (2024-01-01)

Transforming PrEP marketing: understanding the place of PrEP in the hearts and minds of adolescent girls and young women in sub‐Saharan Africa
by: Emily de Lacy Donaldson, et al.
Published: (2025-07-01)

G etting to Implementation for HIV Pre-Exposure Prophylaxis (GTI-PrEP): A data-driven approach to PrEP prescribing
by: Shari S. Rogal, et al.
Published: (2025-06-01)

Barriers to Oral PrEP: A Qualitative Study of Female Sex Workers, PrEP Prescribers, Policymakers, and Community Advocates in Morocco
by: Amal Ben Moussa PhD, et al.
Published: (2024-08-01)

The relationship of PrEP beliefs to perceived personal, interpersonal and structural benefits and barriers to PrEP use in women who inject drugs
by: Kirsten Paulus, et al.
Published: (2023-06-01)

Correlations between oral Pre-Exposure Prophylaxis (PrEP) initiations and policies that enable the use of PrEP to address HIV globally
by: Janki Tailor, et al.
Published: (2022-01-01)

Correlations between oral Pre-Exposure Prophylaxis (PrEP) initiations and policies that enable the use of PrEP to address HIV globally.
by: Janki Tailor, et al.
Published: (2022-01-01)

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
by: Deborah Donnell, et al.
Published: (2023-06-01)

Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age
by: Emily M. Cherenack, et al.
Published: (2022-01-01)

Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age.
by: Emily M Cherenack, et al.
Published: (2022-01-01)

HIV‐1 testing in the context of expanding PrEP modalities
by: Urvi M. Parikh, et al.
Published: (2025-07-01)

Rights-Based PrEP Delivery and Structural Challenges
by: Haoran Deng
Published: (2024-12-01)

Oral PrEP for young African women and men
by: Roberto Parulan Santos
Published: (2016-01-01)

PrEP distribution in pharmacies: a systematic review
by: Laura Ferguson, et al.
Published: (2022-02-01)